Crossmark

Initial Experience with Transarterial Chemoembolization in Metastatic Cutaneous Melanoma Patients with Hepatic Progression on Immune Checkpoint Inhibitors

Crossref DOI link: https://doi.org/10.1007/s00270-025-04218-0

Published Online: 2025-10-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Auer, Timo Alexander

Schlaak, Max

Dobos, Gabor

Savic, Lynn Jeanette

Fleckenstein, Florian Nima

Eigentler, Thomas

Collettini, Federico https://orcid.org/0000-0001-5378-461X
Funding

Funding for this research was provided by:

Charité - Universitätsmedizin Berlin
License Information

Text and Data Mining valid from 2025-10-27

Version of Record valid from 2025-10-27
More Information

Article History

Received: 24 May 2025

Accepted: 21 September 2025

First Online: 27 October 2025

Declarations

:

: There are no conflicts of interests.

Document is current

Any future updates will be listed below